181 related articles for article (PubMed ID: 31075310)
21. Tumor-Infiltrating T Cell Receptor-Beta Repertoires are Linked to the Risk of Late Chemoradiation-Induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma.
Wu L; Chung YL
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):165-176. PubMed ID: 30654091
[TBL] [Abstract][Full Text] [Related]
22. Fatigue following radiation therapy in nasopharyngeal cancer survivors: A dosimetric analysis incorporating patient report and observer rating.
MD Anderson Head Neck Cancer Symptom Working Group
Radiother Oncol; 2019 Apr; 133():35-42. PubMed ID: 30935579
[TBL] [Abstract][Full Text] [Related]
23. Magnetic resonance imaging-based radiomics model for predicting radiation-induced temporal lobe injury in nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Bao D; Zhao Y; Liu Z; Xu H; Zhang Y; Yuan M; Li L; Lin M; Zhao X; Luo D
Head Neck; 2022 Dec; 44(12):2842-2853. PubMed ID: 36161397
[TBL] [Abstract][Full Text] [Related]
24. Radiation-induced nasopharyngeal ulcers after re-irradiation with intensity-modulated radiotherapy in locoregional recurrent nasopharyngeal carcinoma patients: a dose-volume-outcome analysis.
Ni MS; Kong FF; Pan GS; Du CR; Zhai RP; Hu CS; Ying HM
Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1425-1434. PubMed ID: 37995006
[TBL] [Abstract][Full Text] [Related]
25. Normal Tissue Complication Probability Model for Radiation-induced Temporal Lobe Injury after Intensity-modulated Radiation Therapy for Nasopharyngeal Carcinoma.
Zeng L; Huang SM; Tian YM; Sun XM; Han F; Lu TX; Deng XW
Radiology; 2015 Jul; 276(1):243-9. PubMed ID: 25658039
[TBL] [Abstract][Full Text] [Related]
26. Intensity-modulated radiation therapy reduces radiation-induced trismus in patients with nasopharyngeal carcinoma: a prospective study with >5 years of follow-up.
Chen YY; Zhao C; Wang J; Ma HL; Lai SZ; Liu Y; Han F; Lu LX; Bao Y; Chen M
Cancer; 2011 Jul; 117(13):2910-6. PubMed ID: 21264821
[TBL] [Abstract][Full Text] [Related]
27. Application of hypoglossal nerve constraint in definitive radiotherapy for nasopharyngeal carcinoma: A dosimetric feasibility study.
Chow JCH; Lui JCF; Au KH; Cheung KM; Ngan RKC; Leung AKC; Li KWS; Chan JCH; Wong KH; Lee FKH
Med Dosim; 2021 Spring; 46(1):39-44. PubMed ID: 32768273
[TBL] [Abstract][Full Text] [Related]
28. Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: Longitudinal dose-response characterization of quantitative signal kinetics.
Messer JA; Mohamed AS; Hutcheson KA; Ding Y; Lewin JS; Wang J; Lai SY; Frank SJ; Garden AS; Sandulache V; Eichelberger H; French CC; Colen RR; Phan J; Kalpathy-Cramer J; Hazle JD; Rosenthal DI; Gunn GB; Fuller CD
Radiother Oncol; 2016 Feb; 118(2):315-22. PubMed ID: 26830697
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric parameters predict radiation-induced choanal stenosis in patients with nasopharyngeal carcinoma.
Chang H; Chen K; Tao YL; Han F; Ye WJ; Gao YH
Radiat Oncol; 2020 Jun; 15(1):142. PubMed ID: 32503596
[TBL] [Abstract][Full Text] [Related]
30. Advantages of using reduced-volume intensity modulated radiation therapy for the treatment of nasopharyngeal carcinoma: a retrospective paired study.
Liu F; Luo T; Jin T; Zhang J; Xiang Z; Yan R; Xie L; Wu X; Zhang H; Wang F; Li P; Liu L
BMC Cancer; 2019 Jun; 19(1):554. PubMed ID: 31176358
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):327-33. PubMed ID: 21035959
[TBL] [Abstract][Full Text] [Related]
32. Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution study.
Huang CL; Tan HW; Guo R; Zhang Y; Peng H; Peng L; Lin AH; Mao YP; Sun Y; Ma J; Tang LL
Cancer Med; 2019 Nov; 8(16):6887-6893. PubMed ID: 31560840
[TBL] [Abstract][Full Text] [Related]
33. Irradiation-induced nasopharyngeal necrosis (INN) in newly diagnosed nasopharyngeal carcinoma treated by intensity-modulated radiation therapy: clinical characteristics and the influence of treatment strategies.
Xu Y; Liu Y; Wang Z; Wang J; Zhang J; Chen X; Wu R; Liu Q; Qu Y; Wang K; Huang X; Luo J; Gao L; Xu G; Zhang Y; Yi J
Radiat Oncol; 2022 Jan; 17(1):13. PubMed ID: 35062991
[TBL] [Abstract][Full Text] [Related]
34. Echo-Tracking Technique in Ultrasonography Can Monitor Changes in Carotid Artery Elastic Function at Early Stage of Intensity-Modulated Radiation Therapy for Nasopharyngeal Carcinoma.
Han W; Liu J; Liu Z; Zhu X
Med Sci Monit; 2020 Sep; 26():e926260. PubMed ID: 32903241
[TBL] [Abstract][Full Text] [Related]
35. Temporal lobe injury after re-irradiation of locally recurrent nasopharyngeal carcinoma using intensity modulated radiotherapy: clinical characteristics and prognostic factors.
Liu S; Lu T; Zhao C; Shen J; Tian Y; Guan Y; Zeng L; Xiao W; Huang S; Han F
J Neurooncol; 2014 Sep; 119(2):421-8. PubMed ID: 24986091
[TBL] [Abstract][Full Text] [Related]
36. High-Dose Static and Dynamic Intensity-Modulated Radiotherapy Combined with Chemotherapy for Patients with Locally Advanced Nasopharyngeal Carcinoma Improves Survival and Reduces Brainstem Toxicity.
Sun PY; Chen YH; Feng XB; Yang CX; Wu F; Wang RS
Med Sci Monit; 2018 Dec; 24():8849-8859. PubMed ID: 30524119
[TBL] [Abstract][Full Text] [Related]
37. A novel dosimetric metrics-based risk model to predict local recurrence in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
Liao W; He J; Liu Z; Tian M; Yang J; Han J; Xiao J
Radiat Oncol; 2021 Sep; 16(1):186. PubMed ID: 34556123
[TBL] [Abstract][Full Text] [Related]
38. Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors.
Zeng L; Tian YM; Sun XM; Chen CY; Han F; Xiao WW; Deng XW; Lu TX
Br J Cancer; 2014 Jan; 110(1):49-54. PubMed ID: 24253503
[TBL] [Abstract][Full Text] [Related]
39. Radiation-induced hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy with or without chemotherapy: Development of a nomogram based on the equivalent dose.
Zhu MY; Wu HJ; Miao JJ; Di MP; Chen BY; Huang HG; Mai HQ; Wang L; Zhao C
Oral Oncol; 2021 Sep; 120():105378. PubMed ID: 34174518
[TBL] [Abstract][Full Text] [Related]
40. A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients.
Yu YH; Xia WX; Shi JL; Ma WJ; Li Y; Ye YF; Liang H; Ke LR; Lv X; Yang J; Xiang YQ; Guo X
Chin J Cancer; 2016 Jun; 35(1):59. PubMed ID: 27357728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
